Search Ontology:
ChEBI

alpha-L-Fucp-(1->2)-alpha-L-Arap-(1->3)-beta-D-GlcpNAc

Term ID
CHEBI:146436
Synonyms
  • 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-alpha-L-arabino-pentopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranose
  • 6-deoxy-alpha-L-galactopyranosyl-(1->2)-alpha-L-arabinopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
  • alpha-L-fucopyranosyl-(1->2)-alpha-L-arabinopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
  • Fuc(a1-2)Ara(a1-3)b-GlcNAc
  • N-[(2R,3R,4R,5S,6R)-4-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of α-L-fucopyranose, α-L-arabinopyranose and 2-acetamido-2-deoxy-β-D-glucopyranose residues joined in sequence by (1→2) and (1→3) glycosidic bonds.
References
  • glygen:G02657BS
  • glytoucan:G02657BS
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-alpha-L-Arap-(1->3)-beta-D-GlcpNAc
Phenotype where environments contain alpha-L-Fucp-(1->2)-alpha-L-Arap-(1->3)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-alpha-L-Arap-(1->3)-beta-D-GlcpNAc
Phenotype affecting alpha-L-Fucp-(1->2)-alpha-L-Arap-(1->3)-beta-D-GlcpNAc
Human Disease Model